Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities

Cites (257)

Items 201–256 of 256

1. Glycogen storage disease type 1 and diabetes: Learning by comparing and contrasting the two disorders
   Fabienne Rajas, Philippe Labrune, Gilles Mithieux · 2013 · Diabetes & Metabolism
2. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy
   Dawn O’Byrne, Sridevi Devaraj, Kazi Nazrul Islam, Roberto Collazo, Lauren McDonald, Scott M. Grundy, Ishwarlal Jialal · 2001 · Metabolism
3. Renal Accumulation of Biglycan and Lipid Retention Accelerates Diabetic Nephropathy
   Joel C. Thompson, Patricia G. Wilson, Katie L. Brandewie, Deepa Taneja, Liliana Schaefer, Bonnie L. Mitchell, Lisa R. Tannock · 2011 · American Journal Of Pathology
4. Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort
   Luke Johnston, Stewart B. Harris, Ravi R. Retnakaran, Adria Giacca, Zhen Liu, Richard Paul Bazinet, Anthony J. Hanley · 2017 · Diabetologia
5. New perspectives on CKD-induced dyslipidemia
   Marcelino Bermúdez-López, David Arroyo, Àngels Betriu, L. Masana, Elvira Fernández, José Manuel Valdivielso · 2017 · Expert Opinion on Therapeutic Targets
6. New Insights into the PPARγAgonists for the Treatment of Diabetic Nephropathy
   Zhanjun Jia, Ying Sun, Guangrui Yang, Aihua Zhang, Songming Huang, Kristina Marie Heiney, Yue Zhang · 2014 · PPAR Research
7. From a glucocentric to a lipocentric approach towards metabolic syndrome
   Mittra, Shivani, Bansal, Vinay S., Bhatnagar, Pradip K. · 2008 · Drug Discovery Today
8. SREBP-1 activation by glucose mediates TGF-β upregulation in mesangial cells
   Lalita Uttarwar, Bo Gao, Alistair John Ingram, Joan C. Krepinsky · 2011 · American Journal of Physiology-Renal Physiology
9. The Pathogenesis of Foam Cell Formation
   Nancy L. Jones, Jerry W. Reagan, Mark C. Willingham · 2000 · Arteriosclerosis Thrombosis and Vascular Biology
10. Plasma NEFA storage in adipose tissue in the postprandial state: sex-related and regional differences
    Koutsari, C., Snozek, C. L. H., Jensen, M. D. · 2008 · Diabetologia
11. New Insights Into Lipid Metabolism in Chronic Kidney Disease
    George A. Kaysen · 2011 · Journal of Renal Nutrition
12. Dyslipidemia in chronic kidney disease: Causes and consequences
    George A. Kaysen · 2006 · Kidney International
13. Perturbations in mitochondrial dynamics by p66Shc lead to renal tubular oxidative injury in human diabetic nephropathy
    Ming Zhan, Irtaza Usman, Jingbo Yu, Liemin Ruan, Xueyan Bian, Jun Jie Yang, Shikun Yang, Lin Sun, Yashpal S. Kanwar · 2018 · Clinical Science
14. Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression
    Yong Su, Qingqing Chen, Keke Ma, Yinghui Ju, Tianjiao Ji, Zhongyuan Wang, Weizu Li, Weiping Li · 2018 · Pharmacological Reports
15. Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes
    Giancarlo Tonolo, Mario Velussi, Enrico Brocco, Cataldo Abaterusso, Andrea Carraro, Giuseppe Morgia, Andrea Ercole Satta, R. Faedda, Avinash Abhyankar, Holger Luthman et al. · 2006 · Kidney International
16. Tangshen Formula Attenuates Diabetic Nephropathy by Promoting ABCA1-Mediated Renal Cholesterol Efflux in db/db Mice
    Peng Liu, Liang Peng, Haojun Zhang, Patrick Ming‐Kuen Tang, Tingting Zhao, Meihua Yan, Hailing Zhao, Xiao‐Ru Huang, Huiyao Lan, Ping Li · 2018 · Frontiers in Physiology
17. SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells
    Guang Chen, Tony Wang, Lalita Uttarwar, Richard Van Krieken, Renzhong Li, Xing Chen, Bo Gao, Ayesha Ghayur, Peter J. Margetts, Joan C. Krepinsky · 2014 · Journal of Molecular Cell Biology
18. Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
    Lars Johansson, Paul D. Hockings, EVA K. JOHNSSON, Nalina Dronamraju, Jill Maaske, Ricardo García‐Sánchez, John P.H. Wilding · 2020 · Diabetes Obesity and Metabolism
19. Podocyte Injury–Driven Lipid Peroxidation Accelerates the Infiltration of Glomerular Foam Cells in Focal Segmental Glomerulosclerosis
    Hara, Satoshi, Kobayashi, Namiko, Sakamoto, Kazuo, Ueno, Toshiharu, Manabe, Shun, Takashima, Yasutoshi, Hamada, Juri, Pastan, Ira, Fukamizu, Akiyoshi, Matsusaka, Taiji et al. · 2015 · The American Journal of Pathology
20. Oxidized LDL, glomerular mesangial cells and collagen
    Hyun Soon Lee · 1999 · Diabetes Research and Clinical Practice
21. Mechanistic insights into pancreatic beta-cell mass regulation by glucose and free fatty acids
    Yoon Sin Oh · 2015 · Anatomy & Cell Biology
22. Lipid Metabolism and Renal Disease
    Christine K. Abrass · 2006 · KARGER eBooks
23. Lipotoxicity-Induced PRMT1 Exacerbates Mesangial Cell Apoptosis via Endoplasmic Reticulum Stress
    Min-Jung Park, Ho Jae Han, Dong‐Il Kim · 2017 · International Journal of Molecular Sciences
24. Advanced Oxidation Protein Products Aggravate Tubulointerstitial Fibrosis Through Protein Kinase C-Dependent Mitochondrial Injury in Early Diabetic Nephropathy
    Li Xiao, Liting Xu, Xiaoyan Hou, Jian Geng, Jianwei Tian, Xiaoting Liu, Xiaoyan Bai · 2018 · Antioxidants and Redox Signaling
25. EXERCISE IN KIDNEY DISEASE AND DIABETES: TIME FOR ACTION
    Alice Caroline Smith, James O. Burton · 2012 · Journal of Renal Care
26. Foam cells and the pathogenesis of kidney disease
    Minseob Eom, Kelly L. Hudkins, Charles E. Alpers · 2015 · Current Opinion in Nephrology & Hypertension
27. Summary of Revisions: Standards of Medical Care in Diabetes—2020
    2019 · Diabetes Care
28. Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy
    Shinnosuke Yamakado, Hiroki Cho, Mikio Inada, Mika Morikawa, Yong-Huang Jiang, Kenji Saito, Kazunari Nakaishi, Satoshi Watabe, Hitomi Takagi, Mugiho Kaneda et al. · 2019 · BMJ Open Diabetes Research & Care
29. Oligonol, a low-molecular-weight polyphenol derived from lychee fruit, attenuates gluco-lipotoxicity-mediated renal disorder in type 2 diabetic db/db mice
    Chan Hum Park, Jeong Sook Noh, Hajime Fujii, Seong‐Soo Roh, Yeong‐Ok Song, Jae Sue Choi, Hae Young Chung, Takako Yokozawa · 2015 · Drug Discoveries & Therapeutics
30. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats
    Mitsuru Okada, Tsukasa Takemura, Hidehiko Yanagida, Kazuo Yoshioka · 2002 · Kidney International
31. Moderate Intensity Training Impact on the Inflammatory Status and Glycemic Profiles in NOD Mice
    Roberto Codella, Giacomo Lanzoni, Alessia Zoso, Andrea Caumo, Anna Montesano, Ileana M. Terruzzi, Camillo Ricordi, Livio Luzi, Luca Inverardi · 2015 · Journal of Diabetes Research
32. Omacor(R), n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals
    Ho Jun Chin, Y. Y. Fu, Joong Mo Ahn, Ki Young Na, Y. S. Kim, Sungsoo Kim, Dong‐Wan Chae · 2009 · Nephrology Dialysis Transplantation
33. Lipid mediators of insulin signaling in diabetic kidney disease
    Alla V. Mitrofanova, Marie Anne Sosa, Alessia Fornoni · 2019 · American Journal of Physiology-Renal Physiology
34. The role of kidney in the inter-organ coordination of endogenous glucose production during fasting
    Keizo Kaneko, Maud Soty, Carine Zitoun, Adeline Duchampt, Marine Silva, Erwann Philippe, Amandine Gautier‐Stein, Fabienne Rajas, Gilles Mithieux · 2018 · Molecular Metabolism
35. ABCA1 agonist peptides for the treatment of disease
    John Kevin Bielicki · 2015 · Current Opinion in Lipidology
36. Stagnation of autophagy: A novel mechanism of renal lipotoxicity
    Yoshitsugu Takabatake, Takeshi Yamamoto, Yoshitaka Isaka · 2017 · Autophagy
37. Dibenzoylmethane ameliorates lipid-induced inflammation and oxidative injury in diabetic nephropathy
    Eun Young Lee, Mi-Hye Kwon, Hong Min Kim, Nami Kim, You Mi Kim, Hyeon Soo Kim, Eun Young Lee, Choon Hee Chung · 2018 · Journal of Endocrinology
38. Metabolic imaging of fatty kidney in diabesity: validation and dietary intervention
    Jacqueline T. Jonker, Paul de Heer, Marten A. Engelse, Evelien H van Rossenberg, Céline Q.F. Klessens, Hans J. Baelde, Ingeborg M. Bajema, S.J. Koopmans, Paulo G Coelho, Trea C.M. Streefland et al. · 2017 · Nephrology Dialysis Transplantation
39. Differential kidney proximal tubule cell responses to protein overload by albumin and its ligands
    Kimberly R. Long, Youssef Rbaibi, Megan L. Gliozzi, Qidong Ren, Ora A. Weisz · 2020 · American Journal of Physiology-Renal Physiology
40. Intracellular Lipid Droplets: From Structure to Function
    Stefano Vanni · 2017 · Lipid Insights
41. Urine proteome analysis by C18 plate–matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy
    Chao‐Jung Chen, Wen‐Ling Liao, Chiz-Tzung Chang, Hsin-Yi Liao, Fuu‐Jen Tsai · 2018 · PLoS ONE
42. Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition
    Patricia G. Wilson, Joel C. Thompson, Meghan H. Yoder, Richard J. Charnigo, Lisa R. Tannock · 2017 · Journal of Lipid Research
43. Finding diabetic nephropathy biomarkers in the plasma peptidome by high‐throughput magnetic bead processing and MALDI‐TOF‐MS analysis
    Henning Gram Hansen, Anne Julie Overgaard, Maria Lajer, František Hubálek, Peter Højrup, Lykke Pedersen, Lise Tarnow, Peter R Rossing, Flemming Pociot, James N. McGuire · 2010 · PROTEOMICS - CLINICAL APPLICATIONS
44. Glomerulosclerosis in Adriamycin-induced nephrosis is accelerated by a lipid-rich diet
    Hongmei Song, Xuewang Li, Chuanyou Zhu, Minggang Wei · 2000 · Pediatric Nephrology
45. Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy
    Xinglong Cui, Akifumi Kushiyama, Masayasu Yoneda, Yusuke Nakatsu, Ying Guo, Jun Zhang, Haruya Ono, Machi Kanna, Hideyuki Sakoda, Hiraku Ono et al. · 2009 · Diabetes Research and Clinical Practice
46. Enhanced SCAP Glycosylation by Inflammation Induces Macrophage Foam Cell Formation
    Chao Zhou, Han Lei, Yaxi Chen, Qing Liu, Lung‐Chih Li, J F Moorhead, Zac Varghese, Xiong Zhong Ruan · 2013 · PLoS ONE
47. Cholesterol Accumulation in Podocytes: A Potential Novel Targetable Pathway in Diabetic Nephropathy
    Alda Tufró · 2013 · Diabetes
48. Hypolipidemic and Antioxidant Properties of Oryzanol Concentrate in Reducing Diabetic Nephropathy via SREBP1 Downregulation Rather than β‐Oxidation
    G. Bhaskaragoud, Geetha V., Sharanappa T. Talawar, Mohan Kumar A. S., Hema Kumar C., Suresh Kumar G · 2018 · Molecular Nutrition & Food Research
49. Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs
    Yi Liu, Zong Bao Wang, Wei Hsian Yin, Qin Kai Li, Man Bo Cai, Jian Yu, Hong Guang Li, Chi Zhang, Xiu Hong Zu · 2011 · Lipids in Health and Disease
50. Tubular epithelial cells have the capacity to transdifferentiate into CD68-positive macrophage-like cells by oxidative stress
    Marenao Tanaka, Yusuke Suzuki, Isao Shirato, H. Takahara, Terumi Shibata, Takeshi Sugaya, Kazuaki Shimamoto, Satoshi Horikoshi, Yasuhiko Tomino · 2008 · Inflammation Research
51. Very-Low-Density Lipoprotein-Induced Triglyceride Accumulation in Human Mesangial Cells Is Mainly Mediated by Lipoprotein Lipase
    Jing Li, Hang Li, Yu-bing Wen, Xuewang Li · 2008 · Nephron Physiology
52. Changes in lipid droplets morphometric features in mammary epithelial cells upon exposure to non-esterified free fatty acids compared with VLDL
    Ronit Mesilati‐Stahy, Nurit Argov-Argaman · 2018 · PLoS ONE
53. Metabolism and Vascular Fatty Acid Transport
    Deborah M. Muoio · 2010 · New England Journal of Medicine
54. NMR identifies atherogenic lipoprotein abnormalities in early diabetic nephropathy that are unrecognized by conventional analysis
    Hania Z. Al-Shahrouri, P. Ramirez, Paolo Fanti, H. E. Abboud, Carlos Lorenzo, Steven M. Haffner · 2010 · Clinical Nephrology
55. The DiRECT principles: giving Type 2 diabetes remission programmes the best chance of success
    M. Hopkins, Roy Taylor, Michael E. J. Lean · 2019 · Diabetic Medicine
56. Aspirin attenuates podocyte injury in diabetic rats through overriding cyclooxygenase-2-mediated dysregulation of LDL receptor pathway
    Kun Ling Ma, Liang Liu, Yang Zhang, Gui Hua Wang, Ze Bo Hu, Pei Pei Chen, Jian Lü, Chen Lu, Tie Kai Gong, Yu Xiang Gong et al. · 2019 · International Urology and Nephrology